Financial Year |
March 31 2023 |
Monetary Funds |
992,827,537.28 |
Held-for-trading Financial Assets |
736,726,827.82 |
Notes Receivable |
1,553,740,630.55 |
Accounts Receivable |
3,384,108,065.64 |
Advances to Suppliers |
224,466,788.51 |
Other Receivables |
61,456,180.12 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,458,110,014.81 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
106,088,805.21 |
Total Current Assets |
9,517,524,849.94 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
37,709,022.82 |
Long-term Equity Investment |
14,578,125.72 |
Investment Properties |
424,857,766.87 |
Fixed Assetes |
4,313,507,133.80 |
Under-construction Projects |
480,618,182.47 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
481,116,610.88 |
R&D expenses |
-- |
Goodwill |
13,411,268.49 |
Long-Term Deferred and Prepaid Expenses |
224,452,624.60 |
Deferred Income Tax Assets |
444,593,198.25 |
Other Non-Current Assets |
226,889,307.57 |
Sub-Total of Non-Current Assets |
6,668,016,924.87 |
Total Assets |
16,185,541,774.81 |
Short-Term Loans |
41,557,002.50 |
Trading Financial liabilities |
-- |
Notes Payable |
652,008,213.42 |
Accounts Payable |
1,135,382,534.82 |
Accounts Received In Advance |
843,625.58 |
Employee Compensation Payable |
381,006,805.66 |
Taxes Payable |
195,731,958.78 |
Interest Payable |
50,354.97 |
Dividend Payable |
174,293,828.64 |
Other payables |
277,446,879.09 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,772,255.14 |
Other Current Liabilities |
3,934,805.97 |
Sub-Total of Current Liabilities |
2,761,379,981.03 |
Long-term Loans |
596,150,389.57 |
Bonds Payable |
1,734,505,203.76 |
Long-Term Accounts Payable |
62,546,683.40 |
Special Payable |
-- |
Estimatied Liabilities |
22,421,248.42 |
Deferred Income Tax Liabilities |
304,649,398.51 |
Other Non-Current Liabilities |
108,295.95 |
Sub-Total of Non-Current Liabilities |
3,081,086,996.93 |
Total Liabilities |
5,842,466,977.96 |
Paid-In Capital(Or Share Stock) |
1,042,674,562.00 |
Capital Surplus |
30,449,021.67 |
Surplus Reserve |
1,053,673,740.93 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
5,338,721,780.17 |
Minority Stockholder's Interest |
2,521,626,478.15 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,821,448,318.70 |
Owner's Equity(Stockholder's Equity) |
10,343,074,796.85 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
16,185,541,774.81 |